FDA PMA
FDA Class 3
30-Day Notice Accepted
🇺🇸 United States
Drug-Eluting Peripheral Transluminal Angioplasty Catheter
PMA: P140010
·
Supplement: S075
·
Decision Aug 30, 2023
Classifications
1
FEI Numbers
26
Registration Numbers
26
Basic Information
- Device Name
- Drug-Eluting Peripheral Transluminal Angioplasty Catheter
- Trade Name
- IN.PACT Admiral Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter, IN.PACT 018 Paclitaxel-C
- PMA Number
- P140010
- Supplement Number
- S075
- Device Class
- FDA Class 3
- Product Code
- ONU
- Generic Name
- Drug-Eluting Peripheral Transluminal Angioplasty Catheter
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- 30-Day Notice Accepted
- Decision Code
- OK30
- Decision Date
- August 30, 2023
- Date Received
- August 25, 2023
- Supplement Type
- 30-Day Notice
- Supplement Reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
Move manufacturing lines from one building to another building.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| ONU | Drug-Eluting Peripheral Transluminal Angioplasty Catheter | FDA class 3 | Unknown |